Evidence map›Paper›PMID 36593834›Full record

ArticleHeliyon2022

Cognitive enhancing effects and anticholinesterase activity of stem bark and leaf extracts of

David N Ngai, Cromwell M Kibiti, Mathew Piero Ngugi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

David N NgaiDepartment of Biochemistry, Microbiology and Biotechnology, School of Pure and Applied Sciences, Kenyatta University, P. O. Box 43844-00100, Nairobi, Kenya.
Cromwell M KibitiDepartment of Pure and Applied Sciences, Technical University of Mombasa, P. O. Box 90420-80100, Mombasa, Kenya.
Mathew Piero NgugiDepartment of Biochemistry, Microbiology and Biotechnology, School of Pure and Applied Sciences, Kenyatta University, P. O. Box 43844-00100, Nairobi, Kenya.
Kenyatta University · KETechnical University of Mombasa · KE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease is ranked among the top five causes of death for old people. Globally, it is approximated that there are 7.7 million new cases of Alzheimer's disease per annum and it is expected that by the year 2050, as many as 1.5% of people will be victims of Alzheimers or other types of dementia. Currently there is no cure for Alzheimer's disease and the conventional therapeutics agents available either have low efficacy or are associated with serious side effects. In the current study,

Indexed as

AcetylcholineAlzheimer's diseaseAnticholinesteraseCognitionPassive avoidance task

Identifiers

PMID36593834
PMCPMC9803689
OpenAlexW4312221570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.